4 Endometrial Cancer Clinical Trials in New Haven, CT (2026)

Q: How do I join a clinical trial in New Haven?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you.

Recruiting Endometrial Cancer Studies in New Haven

NCT06952504Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Researchers are looking for new ways to treat people with proficient mismatch repair (pMMR) endometrial cancer (EC) that is advanced or recurrent. * EC is a type of cancer that starts in the tissues ...

New Haven, CTPHASE31,123 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06340568Recruiting

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth factor receptor 2 (HER2) in their tumor sample. In ...

New Haven, CTPHASE3480 participantsBioNTech SE

View Study Details

NCT02491099Recruiting

A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma

Primary Objective: To assess the activity of Afatinib in patients with persistent or recurrent uterine serous carcinoma overexpressing HER2/neu with the frequency of patients who survive progression-f...

New Haven, CTPHASE250 participantsYale University

View Study Details

NCT03832361Recruiting

Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer

The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial cancers that overexpress folate receptor alpha (FRα...

New Haven, CTPHASE250 participantsAlessandro Santin

View Study Details

About Endometrial Cancer Clinical Trials in New Haven

Endometrial cancer begins in the lining of the uterus and is the most common gynecologic cancer. It is often detected early due to abnormal bleeding symptoms. Treatment typically involves surgery, with radiation, chemotherapy, or hormone therapy for advanced cases.

There are currently 4 endometrial cancer clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 1,703 participants. Research is being sponsored by Merck Sharp & Dohme LLC, BioNTech SE, Yale University and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Endometrial Cancer Clinical Trials in New Haven — FAQ

Are there endometrial cancer clinical trials in New Haven?

Yes, there are 4 endometrial cancer clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Haven?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.

Are clinical trials in New Haven free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.

What endometrial cancer treatments are being tested?

The 4 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for endometrial cancer.

Data updated October 12, 2026 from ClinicalTrials.gov